Milsaperidone
VP-VHX-896-3201
Phase 3 small_molecule active
Quick answer
Milsaperidone for Major Depressive Disorder (MDD) is a Phase 3 program (small_molecule) at Vanda Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vanda Pharmaceuticals
- Indication
- Major Depressive Disorder (MDD)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active